Roivant Sciences (ROIV) Net Income (2020 - 2026)
Roivant Sciences' Net Income came in at -$290.61 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$273.91 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) Net Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Roivant Sciences reported Net Income of -$414.6 million; for FY2026 (ended Mar 31, 2026), it came in at -$397.91 million.
- Going back by fiscal year, Net Income was -$356.73 million in FY2025, $4.23 billion in FY2024, -$1.12 billion in FY2023 and -$924.12 million in FY2022.
- The five-year range for quarterly Net Income is -$384.9 million (fiscal Q3 2023) to $5.07 billion (fiscal Q3 2024).
- Business Quant data shows ROIV's Net Income at $355.74 million (Q4 2026), -$313.7 million (Q3 2026) and -$166.04 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Roivant Sciences | 26.44 Bn | 9.39 Bn | 1.16 Mn | -290.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -290.61 Mn |
| Mar 31, 2026 | 355.74 Mn |
| Dec 31, 2025 | -313.70 Mn |
| Sep 30, 2025 | -166.04 Mn |
| Jun 30, 2025 | -273.91 Mn |
| Mar 31, 2025 | -252.38 Mn |
| Dec 31, 2024 | 169.38 Mn |
| Sep 30, 2024 | -279.92 Mn |
| Jun 30, 2024 | 57.49 Mn |
| Mar 31, 2024 | -64.78 Mn |
| Dec 31, 2023 | 5.07 Bn |
| Sep 30, 2023 | -331.12 Mn |
| Jun 30, 2023 | -327.85 Mn |
| Mar 31, 2023 | -15.46 Mn |
| Dec 31, 2022 | -384.90 Mn |
| Sep 30, 2022 | -315.92 Mn |
| Jun 30, 2022 | -353.78 Mn |
| Mar 31, 2022 | -291.31 Mn |
| Dec 31, 2021 | -306.09 Mn |
| Sep 30, 2021 | -225.64 Mn |
API Access
Roivant Sciences Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();